Pap, with all due respect you were one of the people happily engaging in very speculative valuations.
Did you really think a company/Sanofi was going to hand over a huge deal overnight that would make UNS profitable and re-rate their SP?
My expectation for a long time is that there was no AMAZING ECONOMIC driver that was going to see a pharma rush into massive deals overnight. That windown closed in my eyes about 12 months ago.
What we got is more the reality of how the company is going to evolve into sustainable business. Steps. This could well elevolve into the 70MM annual deal that was talked about 10 months ago.
Yes, Sanofi are a little quiet re the UNS announcement. Granted. But the good thing is we get a few dollars for now and now the product will soon be known in the market place as a Sanofi product...not some start up spec. product.
So Sanofi can take over pumping the merits of the device as to why it should be used over generics etc
UNS Price at posting:
55.0¢ Sentiment: None Disclosure: Held
